Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases (Q43919851)

28 November 2017

Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases (English)

1 reference

28 November 2017

3

Hamphrey Ham

1 reference

28 November 2017

Jeroen Mertens

1

1 reference

28 November 2017

André Dobbeleir

2

1 reference

28 November 2017

Yves D'Asseler

4

1 reference

28 November 2017

Ingeborg Goethals

5

1 reference

28 November 2017

Christophe Van de Wiele

6

1 reference

28 November 2017

15 June 2012

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

28 November 2017

1 reference

28 November 2017

39

1 reference

28 November 2017

9

1 reference

28 November 2017

1441-1448

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-012-2166-0

28 November 2017

0 references

cites work

18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

Comparative assessment of methods for estimating tumor volume and standardized uptake value in (18)F-FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

Quantitative analysis of PET studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

Partial-volume effect in PET tumor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

Partial volume correction strategies for quantitative FDG PET in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

The effect of acquisition time on visual and semi-quantitative analysis of F-18 FDG-PET studies in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

Comparative evaluation of scatter correction techniques in 3D positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

The use of FDG-PET to target tumors by radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

PET-CT for radiotherapy treatment planning and response monitoring in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

PET functional volume delineation: a robustness and repeatability study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

Positron-emission tomography and assessment of cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

Monitoring chemotherapy and radiotherapy of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2166-0

Monitoring cancer treatment with PET/CT: does it make a difference?

21 January 2018

1 reference

12 December 2020

Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study

1 reference

12 December 2020

Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy

1 reference

12 December 2020

Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancer.

1 reference

12 December 2020

The prognostic value of functional tumor volume and total lesion glycolysis in patients with colorectal cancer liver metastases undergoing 90Y selective internal radiation therapy plus chemotherapy

1 reference

12 December 2020

10.1007/S00259-012-2166-0

Identifiers

DOI

1 reference

28 November 2017

1 reference